Receipt of Antibiotics in Hospitalized Patients and Risk for Clostridium difficile Infection in Subsequent Patients Who Occupy the Same Bed
- PMID: 27723860
- PMCID: PMC5138095
- DOI: 10.1001/jamainternmed.2016.6193
Receipt of Antibiotics in Hospitalized Patients and Risk for Clostridium difficile Infection in Subsequent Patients Who Occupy the Same Bed
Abstract
Objective: To assess whether receipt of antibiotics by prior hospital bed occupants is associated with increased risk for CDI in subsequent patients who occupy the same bed.
Design, setting, and participants: This is a retrospective cohort study of adult patients hospitalized in any 1 of 4 facilities between 2010 and 2015. Patients were excluded if they had recent CDI, developed CDI within 48 hours of admission, had inadequate follow-up time, or if their prior bed occupant was in the bed for less than 24 hours.
Main outcomes and measures: The primary exposure was receipt of non-CDI antibiotics by the prior bed occupant and the primary outcome was incident CDI in the subsequent patient to occupy the same bed. Incident CDI was defined as a positive result from a stool polymerase chain reaction for the C difficile toxin B gene followed by treatment for CDI. Demographics, comorbidities, laboratory data, and medication exposures are reported.
Results: Among 100 615 pairs of patients who sequentially occupied a given hospital bed, there were 576 pairs (0.57%) in which subsequent patients developed CDI. Receipt of antibiotics in prior patients was significantly associated with incident CDI in subsequent patients (log-rank P < .01). This relationship remained unchanged after adjusting for factors known to influence risk for CDI including receipt of antibiotics by the subsequent patient (adjusted hazard ratio [aHR], 1.22; 95% CI, 1.02-1.45) and also after excluding 1497 patient pairs among whom the prior patients developed CDI (aHR, 1.20; 95% CI, 1.01-1.43). Aside from antibiotics, no other factors related to the prior bed occupants were associated with increased risk for CDI in subsequent patients.
Conclusions and relevance: Receipt of antibiotics by prior bed occupants was associated with increased risk for CDI in subsequent patients. Antibiotics can directly affect risk for CDI in patients who do not themselves receive antibiotics.
Conflict of interest statement
Disclosures: None.
Figures
Comment in
-
Prescribing antibiotics to hospitalised patients increases the risk of Clostridium difficile infection for the next bed occupant.Evid Based Med. 2017 Dec;22(6):212. doi: 10.1136/ebmed-2017-110725. Epub 2017 Oct 25. Evid Based Med. 2017. PMID: 29070507 No abstract available.
Similar articles
-
Proton Pump Inhibitors Do Not Increase Risk for Clostridium difficile Infection in the Intensive Care Unit.Am J Gastroenterol. 2016 Nov;111(11):1641-1648. doi: 10.1038/ajg.2016.343. Epub 2016 Aug 30. Am J Gastroenterol. 2016. PMID: 27575714 Free PMC article.
-
Proton pump inhibitors and risk for recurrent Clostridium difficile infection among inpatients.Am J Gastroenterol. 2013 Nov;108(11):1794-801. doi: 10.1038/ajg.2013.333. Epub 2013 Sep 24. Am J Gastroenterol. 2013. PMID: 24060760 Free PMC article.
-
Influence of antibiotics and case exposure on hospital-acquired Clostridium difficile infection independent of illness severity.J Hosp Infect. 2017 Apr;95(4):400-409. doi: 10.1016/j.jhin.2016.10.007. Epub 2016 Oct 14. J Hosp Infect. 2017. PMID: 27825674
-
The magnitude and duration of Clostridium difficile infection risk associated with antibiotic therapy: a hospital cohort study.PLoS One. 2014 Aug 26;9(8):e105454. doi: 10.1371/journal.pone.0105454. eCollection 2014. PLoS One. 2014. PMID: 25157757 Free PMC article.
-
Risk of organism acquisition from prior room occupants: An updated systematic review.Infect Dis Health. 2023 Nov;28(4):290-297. doi: 10.1016/j.idh.2023.06.001. Epub 2023 Jun 27. Infect Dis Health. 2023. PMID: 37385863 Review.
Cited by
-
A call to action: the SHEA research agenda to combat healthcare-associated infections.Infect Control Hosp Epidemiol. 2024 Oct 25;45(9):1-18. doi: 10.1017/ice.2024.125. Online ahead of print. Infect Control Hosp Epidemiol. 2024. PMID: 39448369 Free PMC article. No abstract available.
-
Role of bacteriophages in shaping gut microbial community.Gut Microbes. 2024 Jan-Dec;16(1):2390720. doi: 10.1080/19490976.2024.2390720. Epub 2024 Aug 21. Gut Microbes. 2024. PMID: 39167701 Free PMC article. Review.
-
Early identification of a ward-based outbreak of Clostridioides difficile using prospective multilocus sequence type-based Oxford Nanopore genomic surveillance.Infect Control Hosp Epidemiol. 2024 May 6;45(9):1-7. doi: 10.1017/ice.2024.77. Online ahead of print. Infect Control Hosp Epidemiol. 2024. PMID: 38706217 Free PMC article.
-
Diagnostic stewardship to improve patient outcomes and healthcare-associated infection (HAI) metrics.Infect Control Hosp Epidemiol. 2024 Apr;45(4):405-411. doi: 10.1017/ice.2023.284. Epub 2024 Jan 11. Infect Control Hosp Epidemiol. 2024. PMID: 38204365 Free PMC article.
-
A novel approach to correcting attribution of Clostridioides difficile in a healthcare setting.Antimicrob Steward Healthc Epidemiol. 2023 Dec 20;3(1):e246. doi: 10.1017/ash.2023.516. eCollection 2023. Antimicrob Steward Healthc Epidemiol. 2023. PMID: 38156213 Free PMC article.
References
-
- Dubberke ER, Reske KA, Yan Y, Olsen MA, McDonald LC, Fraser VJ. Clostridium difficile--associated disease in a setting of endemicity: identification of novel risk factors. Clin Infect Dis. 2007;45(12):1543–1549. - PubMed
-
- Dubberke ER, Reske KA, Olsen MA, et al. Evaluation of Clostridium difficile-associated disease pressure as a risk factor for C difficile-associated disease. Arch Intern Med. 2007;167(10):1092–1097. - PubMed
-
- Brown K, Valenta K, Fisman D, Simor A, Daneman N. Hospital ward antibiotic prescribing and the risks of Clostridium difficile infection. JAMA Intern Med. 2015;175(4):626–633. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
